The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
mortality and cost of treating patients with chronic kidney disease (CKD). In the US alone, the number of patients with CKD is growing steadily and currently approaches 400,000. The total cost of ...